Select for export Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2066650 PubMed 35426754 Copy citation Copy BibTeX Expert Opinion on Drug Safety 2022-04-26 Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Randomized Controlled Trial More
Select for export Models of psychedelic drug action: modulation of cortical-subcortical circuits. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/brain/awab406 PubMed 34897383 Copy citation Copy BibTeX Brain 2022-03-31 Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/dta.3255 PubMed 35312166 Copy citation Copy BibTeX Drug Testing and Analysis 2022-03-28 Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y Europe PMC Published psilocybinpsilocin PharmacologyBiomarkersEpigenetics Clinical Trial More
Select for export Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/jcm11040938 PubMed 35207210 Copy citation Copy BibTeX Unknown journal 2022-02-10 Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF Europe PMC Published psilocybin DepressionRandomized Controlled TrialMeta-Analysis Randomized Controlled Trial More
Select for export The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpainsymman.2022.01.024 PubMed 35157985 Copy citation Copy BibTeX Unknown journal 2022-02-10 Maia LO, Beaussant Y, Garcia ACM. Europe PMC Published psilocybin AnxietySpiritualityRandomized Controlled Trial Randomized Controlled Trial More
Select for export Genomic Analysis of Stropharia rugosoannulata Reveals Its Nutritional Strategy and Application Potential in Bioremediation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/jof8020162 PubMed 35205916 Copy citation Copy BibTeX Journal of Fungi 2022-02-05 Yang Y, Meng G, Ni S, Zhang H, Dong C. Europe PMC Published psilocybin PharmacologyGenomics Other More
Select for export Psychedelics hold promise for primary care research Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/fampra/cmac009 PubMed 35137025 Copy citation Copy BibTeX Family Practice 2022-01-23 James Bailey Sanford OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1714-9097 PubMed 35045580 Copy citation Copy BibTeX Unknown journal 2022-01-18 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Systematic Review More
Select for export In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fimmu.2021.794780 PubMed 35095870 Copy citation Copy BibTeX Frontiers in Immunology 2022-01-13 Khan FI, Hassan F, Lai D. Europe PMC Published psilocybinpsilocin Receptor Pharmacology Other More
Select for export The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211064720 PubMed 35090363 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-03 Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J Europe PMC Published psilocybin DepressionReceptor PharmacologyEmotional Processing Randomized Controlled Trial More
Select for export Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1254/jpssuppl.96.0_4-b-s43-2 Copy citation Copy BibTeX Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021-12-31 Daisuke Ibi OpenAlex Published psilocybinpsilocin DepressionPharmacologyMechanism of Action Animal Study More
Select for export Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1254/jpssuppl.95.0_3-s35-1 Copy citation Copy BibTeX Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021-12-31 Daisuke Ibi OpenAlex Published psilocybinpsilocin DepressionNeuroplasticityPharmacology Animal Study More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245221114323 Copy citation Copy BibTeX Drug Science Policy and Law 2021-12-31 Rayyan Zafar, Dustin Sulak, Jaime Brambila, David Nutt, Anne Katrin Schlag OpenAlex Published psilocybin End-of-Life DistressChronic PainPharmacology Other More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Standards Without Labs: Drug Development in the Psychedelic Underground Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5334/cstp.527 Copy citation Copy BibTeX Citizen Science Theory and Practice 2021-12-31 John Bailey, Joanna Kempner OpenAlex Published psilocybin Headache / MigraineClinical Trial Clinical Trial More
Select for export An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245221124117 Copy citation Copy BibTeX Drug Science Policy and Law 2021-12-31 F. N. Smith, Joanna C. Neill, Verity Wainwright OpenAlex Published psilocybin Clinical TrialVeteransSafety Clinical Trial More
Select for export Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1568026621666211201145800 PubMed 34852736 Copy citation Copy BibTeX Current Topics in Medicinal Chemistry 2021-12-31 Sousa TR, Rema J, Machado S, Novais F. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.831092 PubMed 35370864 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Raison CL, Jain R, Penn AD, Cole SP, Jain S PubMed Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1076459 PubMed 36844032 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM PubMed Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
